NEXENTIS TECHNOLOGIES INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
NEXENTIS TECHNOLOGIES INC. (NXTS) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-31
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.00K.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.28K.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.28K.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.52K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $1.00K 10-K · filed 2026-03-31 |
| 2023-12-31 | $1.28K 10-K · filed 2024-04-01 |
| 2022-12-31 | $3.28K 10-K · filed 2023-03-27 |
| 2021-12-31 | $3.52K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |